Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

NCT04396873 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT04396873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04396873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Phase 1
Overall status
Recruiting
Start date
August 17, 2021
Completion date
October 3, 2030
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als, alzheimer's disease, dementia, mild cognitive impairment, parkinson's disease